Literature DB >> 29276044

Intraclonal variations of resistance and phenotype in Pseudomonas aeruginosa epidemic high-risk clone ST308: A key to success within a hospital?

F Abdouchakour1, F Aujoulat1, P Licznar-Fajardo2, H Marchandin3, M Toubiana1, S Parer2, A Lotthé2, E Jumas-Bilak4.   

Abstract

Most multidrug-resistant (MDR) and extensively drug-resistant (XDR) P. aeruginosa strains belonged to epidemic high-risk (EHR) clones that succeeded worldwide in the context of hospital outbreaks. In order to study the intraclonal diversity in EHR P. aeruginosa, we selected clinical and environmental strains of the EHR clone ST308 that caused outbreak clusters over five years in a hospital and then persisted in the hospital environment during four additional years, causing sporadic infections. Unexpectedly, resistance phenotype was very diverse within the population, independently of the origin (environmental or human) and the period of isolation (during or after outbreaks). Most MDR/XDR strains belonged to clusters in pulsed-field gel electrophoresis (PFGE) while singleton strains instead displayed susceptible or moderately resistant phenotypes. High diversity was observed for motility and biofilm formation without correlation with the origin and the period. Resistance to biocides was not linked to epidemic success or to environmental persistence. Finally, the EHR clone ST308 did not display common adaptive traits, nor traits related to an origin or a period of isolation in the hospital. The major character of this EHR clone ST308 is its intraclonal diversity that probably warrants its adaptation and persistence in hospital whatever the conditions and therefore its epidemic behaviour. This diversity could result from adaptive radiation with the evolution of multiple lineages that fill available niches within a complex ecosystem such as a hospital.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Adaptive radiation; Antimicrobial agents resistance; Biofilm; Epidemic high-risk clone; Healthcare-associated infection; Motility

Mesh:

Substances:

Year:  2017        PMID: 29276044     DOI: 10.1016/j.ijmm.2017.11.008

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  4 in total

1.  High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant "high-risk clones" of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals.

Authors:  Gertrudis Horna; Catherine Amaro; Aida Palacios; Humberto Guerra; Joaquim Ruiz
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

Review 2.  From Copper Tolerance to Resistance in Pseudomonas aeruginosa towards Patho-Adaptation and Hospital Success.

Authors:  Maxine Virieux-Petit; Florence Hammer-Dedet; Fabien Aujoulat; Estelle Jumas-Bilak; Sara Romano-Bertrand
Journal:  Genes (Basel)       Date:  2022-02-04       Impact factor: 4.096

3.  Association of blaVIM-2, blaPDC-35, blaOXA-10, blaOXA-488 and blaVEB-9 β-Lactamase Genes with Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam in Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Mazen A Sid Ahmed; Faisal Ahmad Khan; Hamad Abdel Hadi; Sini Skariah; Ali A Sultan; Abdul Salam; Abdul Latif Al Khal; Bo Söderquist; Emad Bashir Ibrahim; Ali S Omrani; Jana Jass
Journal:  Antibiotics (Basel)       Date:  2022-01-19

4.  Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa in Singapore.

Authors:  Jocelyn Qi-Min Teo; Cheng Yee Tang; Jie Chong Lim; Shannon Jing-Yi Lee; Si Hui Tan; Tse-Hsien Koh; James Heng-Chiak Sim; Thuan-Tong Tan; Andrea Lay-Hoon Kwa; Rick Twee-Hee Ong
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.